Skip to main content
Advertisement
Advertisement

SCYX

SCYX logo

SCYNEXIS, Inc.

4.86
USD
Sponsored
+0.46
+10.45%
Sep 22, 15:59 UTC -4
Closed
exchange

Pre-Market

5.10

+0.24
+4.94%

SCYX Earnings Reports

Positive Surprise Ratio

SCYX beat 31 of 43 last estimates.

72%

Next Report

Date of Next Report
Nov 03, 2026
Estimate for Q3 26 (Revenue/ EPS)
$99.96K
/
-$0.62
Implied change from Q2 26 (Revenue/ EPS)
-57.46%
/
-198.41%
Implied change from Q3 25 (Revenue/ EPS)
-70.07%
/
-54.41%

SCYNEXIS, Inc. earnings per share and revenue

On Aug 10, 2026, SCYX reported earnings of 0.63 USD per share (EPS) for Q2 26, beating the estimate of -0.51 USD, resulting in a 221.90% surprise. Revenue reached 235.00 thousand, compared to an expected --, with a 0.00% difference. The market reacted with a -6.21% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 3 analysts forecast an EPS of -0.62 USD, with revenue projected to reach 99.96 thousand USD, implying an decrease of -198.41% EPS, and decrease of -57.46% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Champions Oncology, Inc.
Report Date
Sep 10, 2026 For Q1 27
Estimate
-$0.01
Actual
-$0.03
Surprise
-194.12%
logo
PharmaCyte Biotech, Inc. Common Stock
Report Date
Sep 14, 2026 For Q1 27
Estimate
-
Actual
-$0.54
Surprise
-
FAQ
For Q2 2026, SCYNEXIS, Inc. reported EPS of $0.63, beating estimates by 221.9%, and revenue of $235.00K, 0% as expectations.
The stock price moved down -6.21%, changed from $5.16 before the earnings release to $4.83 the day after.
The next earning report is scheduled for Nov 03, 2026.
Based on 3 analysts, SCYNEXIS, Inc. is expected to report EPS of -$0.62 and revenue of $99.96K for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement